預防藥物引發的貧血或血小板減少症

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. （開啟新視窗）

Brunner B, Hoeck M, Schermer E, Streif W, Kiechl-Kohlendorfer U.

來源‎: J Pediatr 2013;163(1):23-8.

檢索‎: PubMed 23351600

DOI碼‎: 10.1016/j.jpeds.2012.12.035

https://www.ncbi.nlm.nih.gov/pubmed/23351600 （開啟新視窗）

Natalizumab use during the third trimester of pregnancy. （開啟新視窗）

Haghikia A, Langer-Gould A, Rellensmann G, Schneider H, Tenenbaum T, Elias-Hamp B, Menck S, Zimmermann J, Herbstritt S, Marziniak M, Kümpfel T, Meinl I, Plavina T, Gold R, Hellwig K.

來源‎: JAMA Neurol 2014;71(7):891-5.

檢索‎: PubMed 24821217

DOI碼‎: 10.1001/jamaneurol.2014.209

https://www.ncbi.nlm.nih.gov/pubmed/24821217 （開啟新視窗）

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. （開啟新視窗）

Mehler K, Oberthuer A, Weisshaar G, Valter M, Vierzig A, Eifinger F.

來源‎: Klin Padiatr 2013;225(5):263-5.

檢索‎: PubMed 23519748

DOI碼‎: 10.1055/s-0033-1333756

https://www.ncbi.nlm.nih.gov/pubmed/23519748 （開啟新視窗）

Drug-induced thrombocytopenia in children. （開啟新視窗）

Reese JA, Nguyen LP, Buchanan GR, Curtis BR, Terrell DR, Vesely SK, George JN.

來源‎: Pediatr Blood Cancer 2013;60(12):1975-81.

檢索‎: PubMed 24038783

DOI碼‎: 10.1002/pbc.24682

https://www.ncbi.nlm.nih.gov/pubmed/24038783 （開啟新視窗）

新生兒醫學

預防藥物引發的貧血或血小板減少症

中文繁體（國語）

預防藥物引發的貧血或血小板減少症

https://assetsnffrgf-a.akamaihd.net/assets/ct/1add6d1d93/images/syn_placeholder_sqr.png

預防藥物引發的貧血或血小板減少症

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. （開啟新視窗）

Natalizumab use during the third trimester of pregnancy. （開啟新視窗）

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. （開啟新視窗）

Drug-induced thrombocytopenia in children. （開啟新視窗）

醫院聯絡委員會（HLC）

醫療資訊匯總

影片

預防藥物引發的貧血或血小板減少症

Patent ductus arteriosus, low platelets, cyclooxygenase inhibitors, and intraventricular hemorrhage in very low birth weight preterm infants. （開啟新視窗）

Natalizumab use during the third trimester of pregnancy. （開啟新視窗）

Hemolytic anemia and methemoglobinemia in a preterm baby as a complication of antenatal intraamnial injection of toluidine blue. （開啟新視窗）

Drug-induced thrombocytopenia in children. （開啟新視窗）

醫院聯絡委員會（HLC）

醫療資訊匯總

影片

選擇你的語言

分享